受强制性开放获取政策约束的文章 - Wayne Mascarella了解详情
无法在其他位置公开访问的文章：5 篇
Bupropion and bupropion analogs as treatments for CNS disorders
FI Carroll, BE Blough, SW Mascarella, HA Navarro, RJ Lukas, MI Damaj
Advances in Pharmacology 69, 177-216, 2014
强制性开放获取政策： US National Institutes of Health
Conformationally Constrained Analogues of N-(Piperidinyl)-5-(4-Chlorophenyl)-1-(2,4- Dichlorophenyl)-4-Methyl-1H-Pyrazole-3-Carboxamide (SR141716 …
Y Zhang, JP Burgess, M Brackeen, A Gilliam, SW Mascarella, K Page, ...
Journal of medicinal chemistry 51 (12), 3526-3539, 2008
强制性开放获取政策： US National Institutes of Health
Synthesis, nicotinic acetylcholine binding, and in vitro and in vivo pharmacological properties of 2′-fluoro-(carbamoylpyridinyl) deschloroepibatidine analogues
PW Ondachi, AH Castro, CW Luetje, CR Wageman, MJ Marks, MI Damaj, ...
ACS chemical neuroscience 7 (7), 1004-1012, 2016
强制性开放获取政策： US National Institutes of Health
Synthesis and physicochemical characterization of (6 S)-5-formiminotetrahydrofolate; a reference standard for metabolomics
AH Lewin, P Silinski, D Zhong, A Gilbert, SW Mascarella, HH Seltzman
Organic & Biomolecular Chemistry 16 (31), 5684-5690, 2018
强制性开放获取政策： US National Institutes of Health
Synthesis and Characterization of the Selective, Reversible PKCβ Inhibitor (9S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4 …
AH Lewin, L Brieaddy, JR Deschamps, GH Imler, SW Mascarella, ...
ACS Chemical Neuroscience 10 (1), 246-251, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
可在其他位置公开访问的文章：35 篇
Structure of the human κ-opioid receptor in complex with JDTic
H Wu, D Wacker, M Mileni, V Katritch, GW Han, E Vardy, W Liu, ...
Nature 485 (7398), 327-332, 2012
强制性开放获取政策： US National Institutes of Health
Designer drugs: a medicinal chemistry perspective
FI Carroll, AH Lewin, SW Mascarella, HH Seltzman, PA Reddy
Annals of the New York Academy of Sciences 1248 (1), 18-38, 2012
强制性开放获取政策： US National Institutes of Health
Emergence and properties of spice and bath salts: a medicinal chemistry perspective
AH Lewin, HH Seltzman, FI Carroll, SW Mascarella, PA Reddy
Life sciences 97 (1), 9-19, 2014
强制性开放获取政策： US National Institutes of Health
Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: possible confounding effects on in vivo and in vitro studies
CJ McElhinny Jr, AH Lewin, SW Mascarella, S Runyon, L Brieaddy, ...
Bioorganic & medicinal chemistry letters 22 (21), 6661-6664, 2012
强制性开放获取政策： US National Institutes of Health
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation
RJ Lukas, AZ Muresan, MI Damaj, BE Blough, X Huang, HA Navarro, ...
Journal of medicinal chemistry 53 (12), 4731-4748, 2010
强制性开放获取政策： US National Institutes of Health
Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation
FI Carroll, BE Blough, SW Mascarella, HA Navarro, JB Eaton, RJ Lukas, ...
Journal of medicinal chemistry 53 (5), 2204-2214, 2010
强制性开放获取政策： US National Institutes of Health
Structure–activity correlations for β-phenethylamines at human trace amine receptor 1
AH Lewin, HA Navarro, SW Mascarella
Bioorganic & medicinal chemistry 16 (15), 7415-7423, 2008
强制性开放获取政策： US National Institutes of Health
Quantitative signaling and structure-activity analyses demonstrate functional selectivity at the nociceptin/orphanin FQ opioid receptor
SD Chang, SW Mascarella, SM Spangler, VV Gurevich, HA Navarro, ...
Molecular pharmacology 88 (3), 502-511, 2015
强制性开放获取政策： US National Institutes of Health
Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2′-fluoro-3′-(substituted phenyl) deschloroepibatidine analogues of 2 …
P Ondachi, A Castro, CW Luetje, MI Damaj, SW Mascarella, HA Navarro, ...
Journal of medicinal chemistry 55 (14), 6512-6522, 2012
强制性开放获取政策： US National Institutes of Health
Design, Synthesis, and Biological Evaluation of (3R)-1,2,3,4-Tetrahydro-7-hydroxy-N-[(1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2 …
CM Kormos, MG Gichinga, R Maitra, SP Runyon, JB Thomas, ...
Journal of Medicinal Chemistry 57 (17), 7367-7381, 2014
强制性开放获取政策： US National Institutes of Health
Synthesis and In Vitro Opioid Receptor Functional Antagonism of Methyl-Substituted Analogues of (3R)-7-Hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4 …
JP Cueva, TB Cai, SW Mascarella, JB Thomas, HA Navarro, FI Carroll
Journal of medicinal chemistry 52 (23), 7463-7472, 2009
强制性开放获取政策： US National Institutes of Health
Analogues of (3R)-7-Hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3 …
SP Runyon, LE Brieaddy, SW Mascarella, JB Thomas, HA Navarro, ...
Journal of medicinal chemistry 53 (14), 5290-5301, 2010
强制性开放获取政策： US National Institutes of Health
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8 …
SD Chang, LE Brieaddy, JD Harvey, AH Lewin, SW Mascarella, ...
ACS chemical neuroscience 6 (12), 1956-1964, 2015
强制性开放获取政策： US National Institutes of Health
Discovery of N-{4-[(3-Hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide Analogues as Selective Kappa Opioid Receptor …
CM Kormos, C Jin, JP Cueva, SP Runyon, JB Thomas, LE Brieaddy, ...
Journal of medicinal chemistry 56 (11), 4551-4567, 2013
强制性开放获取政策： US National Institutes of Health
Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3-and 4-methyl substituents
FI Carroll, MG Gichinga, CM Kormos, R Maitra, SP Runyon, JB Thomas, ...
Bioorganic & medicinal chemistry 23 (19), 6379-6388, 2015
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定